Cutaneous vasculopathy associated with levamisole-adulterated cocaine

Clinical Medicine and Research

Volumn 11, Issue 1, 2013, Pages 26-30

  Tran, Huy ^a   Tan, Debbie ^a   Marnejon, Thomas P ^a,b  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b Northeast Ohio Medical University   (United States)

Author keywords

Anti neutrophilic cytoplasmic antibody; Cocaine; Cutaneous vasculopathy; Levamisole

Indexed keywords

AMPHETAMINE; BENZOYLECGONINE; COCAINE; DOPAMINE; LEVAMISOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE ASSOCIATION; DOPAMINE BRAIN LEVEL; DRUG BLOOD LEVEL; DRUG CONTAMINATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG URINE LEVEL; EAR DISEASE; EUPHORIA; GAS CHROMATOGRAPHY; HUMAN; LABORATORY TEST; LEUKOPENIA; MALE; MASS SPECTROMETRY; PHYSICAL EXAMINATION; PROFIT; PUNCH BIOPSY; RASH; SKIN BLOOD VESSEL DISORDER; THROMBOSIS; UNITED STATES; VASCULAR NECROSIS; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY; COCAINE; DRUG CONTAMINATION; EXANTHEMA; HUMANS; LEUKOPENIA; LEVAMISOLE; MALE; MIDDLE AGED; SKIN; SKIN DISEASES, VASCULAR; SYNDROME;

EID: 84872900624     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2012.1085     Document Type: Article

References (26)

1. Gross RL, Brucker J, Bahce-Altuntas A, Abadi MA, Lipoff J, Kotlyar D, Barland P, Putterman C. A novel cutaneous vasculitis syndrome induced by levamisolecontaminated cocaine. Clin Rheumatol 2011; 30:1385-1392.
2. Jenkins J, Babu K, Hsu-Hung E, Robinson-Bostom L, Kroumpouzos G. ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisoleadulterated cocaine: a distinctive clinicopathologic presentation. J Am Acad Dermatol 2011;65:e14-e16.
3. Menni S, Pistritto G, Gianotti R, Ghio L, Edefonti A. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997;14:477-479.
4. Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 2011;305:1657-1658.
5. Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2011;35:176-178.
6. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 2010;88:408-411.
7. Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, Gambini C, Rizzoni G, Rebora A. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999; 140:948-951.
8. Farmer RW, Malhotra PS, Mays MP, Egger ME, Smith JW, Jortani SA, Spiller H, Bosse GM, Callen JP, Franklin GA. Necrotizing peripheral vasculitis/ vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res 2012;33:e6-e11.
9. Ching JA, Smith DJ Jr. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res 2012;33:e1-e5.
10. Geller L, Whang TB, Mercer SE, Phelps R. Retiform purpura: a new stigmata of illicit drug use? Dermatol Online J 2011;17:7.
11. Buchanan JA, Vogel JA, Eberhardt AM. Levamisoleinduced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 2011;7:83-84.
12. Bradford M, Rosenberg B, Moreno J, Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010;152:758-759.
13. Kouassi E, Caillé G, Léry L, Larivière L, Vézina M. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 1986;7:71-89.
14. Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol 2011;17:193-196.
15. Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005;80:671-673.
16. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 2011;6:2799-2805.
17. Walsh NM, Green PJ, Burlingame RW, Pasternak S, Hanly JG. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010;37:1212-1219.
18. Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, Specks U. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004;50:2954-2965.
19. Gao Y, Zhao MH. Review article: Drug-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton). 2009;14:33-41.
20. Thompson JS, Herbick JM, Klassen LW, Severson CD, Overlin VL, Blaschke JW, Silverman MA, Vogel CL. Studies on levamisole-induced agranulocytosis. Blood 1980;56:388-396.
21. Buchanan JA, Oyer RJ, Patel NR, Jacquet GA, Bornikova L, Thienelt C, Shriver DA, Shockley LW, Wilson ML, Hurlbut KM, Lavonas EJ. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 2010;6:160-164.
22. Mouzakis J, Somboonwit C, Lakshmi S, Rumbak M, Sinnott J, Cherpelis B, Keshishian J. Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome. J Drugs Dermatol 2011;10:1204-1207.
23. Centers for Disease Control and Prevention (CDC). Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. Morb Mortal Wkly Rep 2009;58:1381-1385.
24. Zhu NY, Legatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009;150:287-289.
25. Hanson KA, Heidrick ML. Immunomodulatory action of levamisole-II. Enhancement of concanavalin A response by levamisole is associated with an oxidation degradation product of levamisole formed during lymphocyte culture. Int J Immunopharmacol 1991;13:669-676.
26. Czuchlewski DR, Brackney M, Ewers C, Manna J, Fekrazad MH, Martinez A, Nolte KB, Hjelle B, Rabinowitz I, Curtis BR, McFarland JG, Baumbach J, Foucar K. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010;133:466-472.